(Image: Getty/Monsitj)

Five stories that speak volumes about US generics market

By Ben Hargreaves

As Novartis looks to sell a major chunk of its generics portfolio in the US, in-PharmaTechnologist has a look back at some of the stories this year that have signposted larger, on-going trends in the US generics market.

(Image: Pixabay Skitterphoto)


US FDA launches drug shortages task force

By Ben Hargreaves

The US FDA announced a task force has been formed to prevent the shortage of drugs, by addressing the ‘underlying structural concerns’ that allow this to happen.

Merck joins in generics M&A

Merck joins in generics M&A

Faced with a raft of consolidation in the market for generic
pharmaceuticals, Germany's Merck KGaA has entered the fray with an
agreement to acquire most of NM Pharma, the Scandinavian generics
business of top drugmaker Pfizer.

Teva closer to SICOR merger

Teva closer to SICOR merger

Israel's Teva has moved a step closer to consolidating its position
as the world's biggest generics manufacturer with the $3.4 billion
(€2.7bn) acquisition of US-based SICOR, which makes active
pharmaceutical ingredients...


Follow us


View more


Featured Suppliers